Literature DB >> 15075792

The impact of coding process on observed cancer mortality trends in Switzerland.

J-M Lutz1, P Pury, G Fioretta, L Raymond.   

Abstract

Official cancer mortality in Switzerland decreased by about 16% over the 9-year period 1990-1998 and this trend has often been used to suggest that secondary prevention by screening for breast cancer could be useless. However, the clear downshift observed between 1994 and 1995 for some cancers, such as female breast and prostate, and the simultaneous change in ICD classification used by the Federal Office for Statistics in 1995 (ICD-8 to ICD-10) could be related, suggesting an impact of coding process on the observed trend. For every death occurred between 1980 and 1999, the death certificates have been retrieved, the cause of death has been recoded and site-specific mortality rates have been calculated again for each year during this period. As suggested, the trend appears to be overestimated: in order to be comparable with current rates, the mortality observed before 1995 should be lowered by about 7% for men and 5% for women. The error may be partially due to attributing the cause of death to co-morbidity factors not normally (and nowadays) defined as the underlying cause. Logically, the impact of such a miscoding is more important among older people and for cancer sites with long survival. For instance, the correction should be around 15% for female breast, 12% for prostate and up to 40% for testicular cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15075792     DOI: 10.1097/00008469-200402000-00012

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  8 in total

1.  Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Carlo La Vecchia; Carlo LaVecchia; Lars Vatten; Anna Gavin; Clarisse Héry; Mary Heanue
Journal:  BMJ       Date:  2010-08-11

2.  Leukaemia, brain tumours and exposure to extremely low frequency magnetic fields: cohort study of Swiss railway employees.

Authors:  Martin Röösli; Manfred Lörtscher; Matthias Egger; Dominik Pfluger; Nadja Schreier; Emanuel Lörtscher; Peter Locher; Adrian Spoerri; Christoph Minder
Journal:  Occup Environ Med       Date:  2007-05-24       Impact factor: 4.402

3.  Impact of unlinked deaths and coding changes on mortality trends in the Swiss National Cohort.

Authors:  Kurt Schmidlin; Kerri M Clough-Gorr; Adrian Spoerri; Matthias Egger; Marcel Zwahlen
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-04       Impact factor: 2.796

4.  Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database.

Authors:  Driss Ait Ouakrim; Cécile Pizot; Magali Boniol; Matteo Malvezzi; Mathieu Boniol; Eva Negri; Maria Bota; Mark A Jenkins; Harry Bleiberg; Philippe Autier
Journal:  BMJ       Date:  2015-10-06

5.  Accuracy of cause of death data routinely recorded in a population-based cancer registry: impact on cause-specific survival and validation using the Geneva Cancer Registry.

Authors:  Robin Schaffar; Elisabetta Rapiti; Bernard Rachet; Laura Woods
Journal:  BMC Cancer       Date:  2013-12-27       Impact factor: 4.430

6.  40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland.

Authors:  Christian Herrmann; Silvia Ess; Beat Thürlimann; Nicole Probst-Hensch; Penelope Vounatsou
Journal:  BMC Cancer       Date:  2015-10-09       Impact factor: 4.430

7.  The Swedish cause of death register.

Authors:  Hannah Louise Brooke; Mats Talbäck; Jesper Hörnblad; Lars Age Johansson; Jonas Filip Ludvigsson; Henrik Druid; Maria Feychting; Rickard Ljung
Journal:  Eur J Epidemiol       Date:  2017-10-05       Impact factor: 8.082

8.  Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.

Authors:  Christian Herrmann; Penelope Vounatsou; Beat Thürlimann; Nicole Probst-Hensch; Christian Rothermundt; Silvia Ess
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.